Vascular Calcification in Chronic Kidney Disease: Role of Disordered Mineral Metabolism

Overview

Journal Curr Pharm Des

Publisher Bentham Science Publishers

Date 2014 Feb 19

PMID 24533939

Citations 57

Authors

Shyamal Palit

Jessica Kendrick

Affiliations

Soon will be listed here.

Abstract

In patients with chronic kidney disease (CKD), vascular calcification is associated with significant morbidity and mortality. The prevalence of vascular calcification increases as glomerular filtration rate (GFR) declines and calcification occurs years earlier in CKD patients than in the general population. The mechanisms of vascular calcification in CKD patients are complex and not completely understood but likely involve non-traditional risk factors, which may be unique to patients with CKD. These unique risk factors may predispose patients to early and more accelerated calcification. Experimental and clinical studies show that disorders in mineral metabolisms including calcium and phosphorus homeostasis initiate and promote vascular calcification in patients with CKD. It is currently unknown if vascular calcification can be prevented or reversed with therapies aimed at maintaining calcium and phosphorus homeostasis. This review focuses on the potential mechanisms by which disordered mineral metabolism may promote vascular calcification in patients with CKD.

Citing Articles

Emerging roles of PCSK9 in kidney disease: lipid metabolism, megalin regulation and proteinuria.

Hummelgaard S, Kresse J, Jensen M, Glerup S, Weyer K Pflugers Arch. 2025; .

PMID: 39964484 DOI: 10.1007/s00424-025-03069-5.

Moderate-severe aortic arch calcification and high serum alkaline phosphatase co-modify the risk of cardiovascular events and mortality among chronic hemodialysis patients.

Chang C, Liou H, Wu C Ren Fail. 2025; 47(1):2449572.

PMID: 39801127 PMC: 11731357. DOI: 10.1080/0886022X.2024.2449572.

OTUB2 contributes to vascular calcification in chronic kidney disease via the YAP-mediated transcription of PFKFB3.

Li Y, Chen X, Xu X, Chen C, Min M, Liang D Theranostics. 2025; 15(3):1185-1204.

PMID: 39776804 PMC: 11700865. DOI: 10.7150/thno.98660.

Mineral composition and ratios in aortic valves, serum, and epicardial fat among patients with aortic stenosis undergoing aortic valve replacement.

Poniedzialek B, Perek B, Proch A, Komosa A, Niedzielski P, Buczkowski P Sci Rep. 2025; 15(1):1233.

PMID: 39775052 PMC: 11707200. DOI: 10.1038/s41598-025-85141-9.

Correlation between coronary calcification and cardiac structure in non-dialysis patients with chronic kidney disease.

Rao S, Weng M, Lian R, Zhuo Y, Lin J, You D ESC Heart Fail. 2024; 12(1):199-210.

PMID: 39239806 PMC: 11769669. DOI: 10.1002/ehf2.15057.

References

Bleyer A, Burkart J, Piazza M, Russell G, Rohr M, Carr J . Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD. Am J Kidney Dis. 2005; 46(3):464-9. DOI: 10.1053/j.ajkd.2005.04.035. View

Barreto D, Barreto F, Carvalho A, Cuppari L, Draibe S, Dalboni M . Phosphate binder impact on bone remodeling and coronary calcification--results from the BRiC study. Nephron Clin Pract. 2008; 110(4):c273-83. DOI: 10.1159/000170783. View

Kendrick J, Cheung A, Kaufman J, Greene T, Roberts W, Smits G . Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease. Am J Kidney Dis. 2012; 60(4):567-75. PMC: 3439559. DOI: 10.1053/j.ajkd.2012.04.014. View

Sugitani H, Wachi H, Murata H, Sato F, Mecham R, Seyama Y . Characterization of an in vitro model of calcification in retinal pigmented epithelial cells. J Atheroscler Thromb. 2003; 10(1):48-56. DOI: 10.5551/jat.10.48. View

McIntyre C . Calcium balance during hemodialysis. Semin Dial. 2008; 21(1):38-42. DOI: 10.1111/j.1525-139X.2007.00368.x. View

Shalhoub V, Shatzen E, HENLEY C, Boedigheimer M, McNinch J, Manoukian R . Calcification inhibitors and Wnt signaling proteins are implicated in bovine artery smooth muscle cell calcification in the presence of phosphate and vitamin D sterols. Calcif Tissue Int. 2006; 79(6):431-42. DOI: 10.1007/s00223-006-0126-z. View

Hu M, Shi M, Zhang J, Quinones H, Griffith C, Kuro-O M . Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2010; 22(1):124-36. PMC: 3014041. DOI: 10.1681/ASN.2009121311. View

Benet-Pages A, Orlik P, Strom T, Lorenz-Depiereux B . An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet. 2004; 14(3):385-90. DOI: 10.1093/hmg/ddi034. View

Stubbs J, Liu S, Quarles L . Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Semin Dial. 2007; 20(4):302-8. DOI: 10.1111/j.1525-139X.2007.00308.x. View

10.

Mozar A, Haren N, Chasseraud M, Louvet L, Maziere C, Wattel A . High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells. J Cell Physiol. 2007; 215(1):47-54. DOI: 10.1002/jcp.21283. View

11.

Jono S, McKee M, Murry C, Shioi A, Nishizawa Y, Mori K . Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000; 87(7):E10-7. DOI: 10.1161/01.res.87.7.e10. View

12.

Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O . 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation. 2005; 111(13):1666-71. DOI: 10.1161/01.CIR.0000160353.27927.70. View

13.

Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi S, Nakatani T . Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun. 2001; 280(4):1015-20. DOI: 10.1006/bbrc.2000.4226. View

14.

Rostand S, Drueke T . Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int. 1999; 56(2):383-92. DOI: 10.1046/j.1523-1755.1999.00575.x. View

15.

Mansfield K, Rajpurohit R, Shapiro I . Extracellular phosphate ions cause apoptosis of terminally differentiated epiphyseal chondrocytes. J Cell Physiol. 1999; 179(3):276-86. DOI: 10.1002/(SICI)1097-4652(199906)179:3<276::AID-JCP5>3.0.CO;2-#. View

16.

Jean G, Bresson E, Terrat J, Vanel T, Hurot J, Lorriaux C . Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant. 2008; 24(3):948-55. DOI: 10.1093/ndt/gfn571. View

17.

Ewence A, Bootman M, Roderick H, Skepper J, McCarthy G, Epple M . Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res. 2008; 103(5):e28-34. DOI: 10.1161/CIRCRESAHA.108.181305. View

18.

Proudfoot D, Skepper J, Hegyi L, Bennett M, Shanahan C, Weissberg P . Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 2000; 87(11):1055-62. DOI: 10.1161/01.res.87.11.1055. View

19.

Kendrick J, Chonchol M . The role of phosphorus in the development and progression of vascular calcification. Am J Kidney Dis. 2011; 58(5):826-34. PMC: 3199354. DOI: 10.1053/j.ajkd.2011.07.020. View

20.

Qunibi W, Moustafa M, Muenz L, He D, Kessler P, Diaz-Buxo J . A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis. 2008; 51(6):952-65. DOI: 10.1053/j.ajkd.2008.02.298. View